Sunday, November 17, 2024

LATEST ARTICLES

Pharma

Alvotech Provides Update on FDA Action Regarding AVT02, Proposed High-Concentration Biosimilar to Humira®

Life Sciences Times - 0
Pharma

Poxel Completes Enrollment in Phase 2 NASH Trial for PXL065 (DESTINY-1) in Biopsy-Proven Patients

Life Sciences Times - 0
Pharma

Clinical Investigation Shows Herb-Pharma’s ViroStop Spray Effective in Reducing Impact of Covid-19

Life Sciences Times - 0
Medtech

Happify Health to Distribute its Clinical-Grade, Intelligent Healing Platform Through Microsoft Azure

Life Sciences Times - 0
Public Health

Soleo Health Selected by Houston Methodist as Exclusive In-Home Provider of Infused Monoclonal Antibodies for Treatment of COVID-19

Life Sciences Times - 0
People on the Move

NextGen Healthcare Appoints David Sides President and Chief Executive Officer

Life Sciences Times - 0
Venture Capital

3D BioFibR Inc. Raises New Capital to Scale Up Manufacturing in an Oversubscribed Round

Life Sciences Times - 0
Venture Capital

Thomas H. Lee Partners to Acquire Automation Business from Brooks Automation for $3 Billion in Cash

Life Sciences Times - 0
Venture Capital

Illumina Ventures Closes $325 Million Fund

Life Sciences Times - 0
Pharma

Invetx Announces Initiation of First Clinical Study in Dogs with IVX-01, its Novel Monoclonal Antibody Featuring Half-Life Extension

Life Sciences Times - 0
1...466467468...567Page 467 of 567

Most Popular

Load more

Recent Comments

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Contact us: editorial@mishragroup.com

FOLLOW US

© Newspaper WordPress Theme by TagDiv